Anbio Biotechnology NNNN
NASDAQ NNNN
$3.86 +0.13 (+3.49%)
As of: Oct 21, 2026 · 1:15 PM EDT

Anbio Biotechnology (NNNN) Total Current Liabilities (2023 - 2025)

Updated

Anbio Biotechnology's Total Current Liabilities was $87,836 in the quarter ended Dec 31, 2025, down 94.9% from $1.73 million a year earlier.

Analysis

Anbio Biotechnology (NNNN) Total Current Liabilities (2023 - 2025) Analysis & Trends

From the quarter ended Dec 31, 2023 onward, Anbio Biotechnology has reported Total Current Liabilities for 4 quarters.

  • In earlier years, Total Current Liabilities was $1.73 million in the year ended Dec 31, 2024 (+74.2%) and $993,060 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Thermo Fisher Scientific 258.23 Bn 237.26 Bn 4.88 Bn 15.07 Bn
2 Abbott Laboratories 171.33 Bn 141.76 Bn 7.27 Bn 17.81 Bn
3 Danaher 162.29 Bn 146.09 Bn 3.61 Bn 8.11 Bn
4 Intuitive Surgical 151.16 Bn 130.58 Bn 1.96 Bn 1.92 Bn
5 Medtronic 119.57 Bn 84.82 Bn 6.34 Bn 11.80 Bn
6 Stryker 113.73 Bn 99.85 Bn 4.50 Bn 6.68 Bn
7 Boston Scientific 65.12 Bn 59.89 Bn 3.85 Bn 6.43 Bn
8 Becton Dickinson 53.54 Bn 50.69 Bn 2.32 Bn 9.40 Bn
9 Edwards Lifesciences 50.79 Bn 34.79 Bn 1.35 Bn 1.51 Bn
10 Anbio Biotechnology 171.41 Mn 124.63 Mn - 87,836.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 87,836.00
Jun 30, 2025 131,127.00
Dec 31, 2024 1.73 Mn
Dec 31, 2023 993,060.00
API Access

Anbio Biotechnology Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NNNN&period=max&api_key=YOUR_API_KEY